Trifenagrel

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrifenagrel
Drug Alias Nametrifenagrel三苯格雷trifenagrelumBW-325U
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet aggregation inhibitors
TargetsNot applicable
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksKEGG